# Invesco DB US Dollar Index Bullish Fund: financial statements, quarterly

UUP · NYSE · CIK 1383151 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uup.md) · [Financials](/companies/uup/financials.md) · [Filings](/companies/uup/filings.md) · [Insiders](/companies/uup/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uup/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [6.2](/filings/0000950170-24-122609.md) | [6.8 d](/filings/0001193125-26-083557.md) | [4.3](/filings/0000950170-25-067206.md) | [4.8](/filings/0000950170-25-105201.md) | [4.0](/filings/0001193125-25-270331.md) | [3.5 d](/filings/0001193125-26-083557.md) | [3.8](/filings/0001193125-26-209729.md) | [2.3](/filings/0001193125-26-338699.md) | [1.6](/filings/0001193125-25-270331.md) | [1.9 d](/filings/0001193125-26-083557.md) | [2.1](/filings/0001193125-26-209729.md) | [2.9](/filings/0001193125-26-338699.md) |
| Interest expense | $m | [0.0](/filings/0000950170-23-060463.md) | [0.0 d](/filings/0000950170-24-019064.md) | [0.0](/filings/0000950170-24-054977.md) | [0.0](/filings/0000950170-24-092113.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [21.8](/filings/0000950170-24-122609.md) | [(18.0) d](/filings/0001193125-26-083557.md) | [16.5](/filings/0000950170-25-067206.md) | [10.7](/filings/0000950170-25-105201.md) | [(11.4)](/filings/0001193125-25-270331.md) | [28.7 d](/filings/0001193125-26-083557.md) | [(13.0)](/filings/0001193125-26-209729.md) | [(15.7)](/filings/0001193125-26-338699.md) | [4.2](/filings/0001193125-25-270331.md) | [2.3 d](/filings/0001193125-26-083557.md) | [8.7](/filings/0001193125-26-209729.md) | [4.2](/filings/0001193125-26-338699.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [1.0](/filings/0000950170-25-027275.md) | not reported | not reported | not reported | [0.6](/filings/0001193125-26-083557.md) | not reported | not reported | not reported | [0.0](/filings/0001193125-26-083557.md) | not reported | not reported |
| Total assets | $m | [531](/filings/0000950170-23-060463.md) | [408](/filings/0000950170-25-027275.md) | [333](/filings/0000950170-24-054977.md) | [443](/filings/0000950170-24-092113.md) | [320](/filings/0000950170-24-122609.md) | [430](/filings/0001193125-26-083557.md) | [329](/filings/0000950170-25-067206.md) | [209](/filings/0000950170-25-105201.md) | [154](/filings/0001193125-25-270331.md) | [230](/filings/0001193125-26-338699.md) | [576](/filings/0001193125-26-209729.md) | [448](/filings/0001193125-26-338699.md) |
| Total liabilities | $m | [0.9](/filings/0000950170-23-060463.md) | [19.3](/filings/0000950170-25-027275.md) | [0.2](/filings/0000950170-24-054977.md) | [0.4](/filings/0000950170-24-092113.md) | [0.2](/filings/0000950170-24-122609.md) | [0.2](/filings/0001193125-26-083557.md) | [3.1](/filings/0000950170-25-067206.md) | [7.0](/filings/0000950170-25-105201.md) | [0.1](/filings/0001193125-25-270331.md) | [0.1](/filings/0001193125-26-338699.md) | [3.6](/filings/0001193125-26-209729.md) | [1.6](/filings/0001193125-26-338699.md) |
| Shareholders' equity | $m | [530](/filings/0000950170-24-122609.md) | [389](/filings/0001193125-26-083557.md) | [333](/filings/0000950170-25-105201.md) | [443](/filings/0001193125-25-270331.md) | [320](/filings/0001193125-25-270331.md) | [430](/filings/0001193125-26-338699.md) | [326](/filings/0001193125-26-338699.md) | [202](/filings/0001193125-26-338699.md) | [154](/filings/0001193125-25-270331.md) | [230](/filings/0001193125-26-338699.md) | [573](/filings/0001193125-26-338699.md) | [446](/filings/0001193125-26-338699.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [119 d](/filings/0000950170-24-122609.md) | [106 d](/filings/0001193125-26-083557.md) | [90.0](/filings/0000950170-25-067206.md) | [(96.1) d](/filings/0000950170-25-105201.md) | [109 d](/filings/0001193125-25-270331.md) | [(80.5) d](/filings/0001193125-26-083557.md) | [87.6](/filings/0001193125-26-209729.md) | [104 d](/filings/0001193125-26-338699.md) | [59.9 d](/filings/0001193125-25-270331.md) | [(75.1) d](/filings/0001193125-26-083557.md) | [(334)](/filings/0001193125-26-209729.md) | [130 d](/filings/0001193125-26-338699.md) |
| Share repurchases | $m | [348 d](/filings/0000950170-24-122609.md) | [431 d](/filings/0001193125-26-083557.md) | [313](/filings/0000950170-25-067206.md) | [138 d](/filings/0000950170-25-105201.md) | [310 d](/filings/0001193125-25-270331.md) | [151 d](/filings/0001193125-26-083557.md) | [356](/filings/0001193125-26-209729.md) | [264 d](/filings/0001193125-26-338699.md) | [142 d](/filings/0001193125-25-270331.md) | [101 d](/filings/0001193125-26-083557.md) | [83.0](/filings/0001193125-26-209729.md) | [421 d](/filings/0001193125-26-338699.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 15,700,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338699.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.